BioCentury | Sep 12, 2011
Company News

Arch Biopartners, Emory University, University of Colorado deal

...cancer. GH501a is in preclinical development at the universities. Under a 2010 deal, Arch's Colorado Cancer Therapeutics Inc....
BioCentury | Dec 6, 2010
Company News

Arch Biopartners deal

...Arch received an option to purchase the remaining 33% stake in its Colorado Cancer Therapeutics Inc. subsidiary for...
BioCentury | Sep 27, 2010
Company News

Arch Biopartners, Emory University, University of Colorado deal

...Arch subsidiary, Colorado Cancer Therapeutics Inc. acquired an option to license exclusive rights to develop and commercialize undisclosed...
BioCentury | Oct 26, 2009
Company News

NanoTherapies deal

...On Oct. 16, biotech incubator Cancer Therapeutics Inc. said it will increase its stake in NanoTherapies to 51%...
BioCentury | Jun 8, 2009
Company News

NanoTherapies deal

Cancer Therapeutics Inc. , a biotechnology incubator, will take a 25% stake in NanoTherapies. The biotech is developing calcium phosphate nanoparticles for cancer. Further terms were not disclosed. NanoTherapies LLC , Ashburn, Va. Business: Cancer WIR Staff...
Items per page:
1 - 5 of 5
BioCentury | Sep 12, 2011
Company News

Arch Biopartners, Emory University, University of Colorado deal

...cancer. GH501a is in preclinical development at the universities. Under a 2010 deal, Arch's Colorado Cancer Therapeutics Inc....
BioCentury | Dec 6, 2010
Company News

Arch Biopartners deal

...Arch received an option to purchase the remaining 33% stake in its Colorado Cancer Therapeutics Inc. subsidiary for...
BioCentury | Sep 27, 2010
Company News

Arch Biopartners, Emory University, University of Colorado deal

...Arch subsidiary, Colorado Cancer Therapeutics Inc. acquired an option to license exclusive rights to develop and commercialize undisclosed...
BioCentury | Oct 26, 2009
Company News

NanoTherapies deal

...On Oct. 16, biotech incubator Cancer Therapeutics Inc. said it will increase its stake in NanoTherapies to 51%...
BioCentury | Jun 8, 2009
Company News

NanoTherapies deal

Cancer Therapeutics Inc. , a biotechnology incubator, will take a 25% stake in NanoTherapies. The biotech is developing calcium phosphate nanoparticles for cancer. Further terms were not disclosed. NanoTherapies LLC , Ashburn, Va. Business: Cancer WIR Staff...
Items per page:
1 - 5 of 5